Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model.

Stanczyk, Frank Z; Archer, David F; Lohmer, Lauren R L; Pirone, Jason; Previtera, Michelle; Korner, Paul

Stanczyk, Frank Z; Archer, David F; Lohmer, Lauren R L; Pirone, Jason; Previtera, Michelle; Korner, Paul.

Affiliation

Stanczyk FZ; Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, California, United States of America.
Archer DF; Eastern Virginia Medical School, Norfolk, Virginia, United States of America.
Lohmer LRL; Nuventra, LLC, Durham, North Carolina, United States of America.
Pirone J; Nuventra, LLC, Durham, North Carolina, United States of America.
Previtera M; Agile Therapeutics, Inc., Princeton, New Jersey, United States of America.
Korner P; Agile Therapeutics, Inc., Princeton, New Jersey, United States of America.

PLoS One ; 17(12): e0279640, 2022.

Article in En | MEDLINE | ID: mdl-36574387

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Levonorgestrel / Ethinyl Estradiol Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google